Sort
23,748 grants matching “melanoma”
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
$150,798Jessie Villanueva · Wistar Institute · K01 · FY2015 · CA
Project 1: Nanoshells Enabled Tumor Ablation and Immunotherapy
$150,621Andrew Clyde Kummel · University Of California, San Diego · U54 · FY2015 · CA
Core A: Administrative Core
$150,612Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA
Mitochondrial Targeted Metastatic Melanoma Therapy
$150,594Michael King Schultz · University Of Iowa · K25 · FY2017 · CA
Mitochondrial Targeted Metastatic Melanoma Therapy
$150,594Michael King Schultz · University Of Iowa · K25 · FY2013 · CA
Mitochondrial Targeted Metastatic Melanoma Therapy
$150,594Michael King Schultz · University Of Iowa · K25 · FY2016 · CA
NEUROPATHOLOGY/TISSUE BANK CORE
$150,594Claudia Katharina Petritsch · Stanford University · U54 · FY2022 · CA
Mitochondrial Targeted Metastatic Melanoma Therapy
$150,594Michael King Schultz · University Of Iowa · K25 · FY2014 · CA
Mitochondrial Targeted Metastatic Melanoma Therapy
$150,594Michael King Schultz · University Of Iowa · K25 · FY2015 · CA
Informatics, Tissue Resource, and Pathology Core
$150,540Jeffrey E Gershenwald · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
Thrombocytes in Cancer Immunity
$150,527Zihai Li · Medical University Of South Carolina · R01 · FY2019 · CA
Core A: Administrative Core
$150,513Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA
Analysis of the role of the SWI/SNF complex in tumor suppression
$150,503Charles W Roberts · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Core A: Administrative Core
$150,493Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA
TAS::75 0849::TAS
$150,493Dennis M. Deapen · University Of Southern California · N01 · FY2010 · CA
Mechanical control of cell growth and differentiation
$150,299Paul A Janmey · University Of Pennsylvania · R01 · FY2009 · GM
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
$150,262Andrew V Kossenkov · Wistar Institute · R50 · FY2025 · CA
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
$150,262Andrew V Kossenkov · Wistar Institute · R50 · FY2023 · CA
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
$150,262Andrew V Kossenkov · Wistar Institute · R50 · FY2021 · CA
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
$150,262Andrew V Kossenkov · Wistar Institute · R50 · FY2024 · CA
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
$150,262Andrew V Kossenkov · Wistar Institute · R50 · FY2022 · CA
REGULATION AND INDUCTION OF APOPTOSIS IN SKIN CANCER
$150,197University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
CORE--CLINICAL AND MOLECULAR EPIDEMIOLOGY
$150,197University Of Texas Md Anderson Can Ctr · P01 · FY2000 · CA
CLINICAL TRIAL: PHASE 2: CCI-779 IN COMBINATION WITH BEVACIZUMAB IN STAGE III OR
$150,134Craig Lee Slingluff · University Of Virginia · M01 · FY2009 · RR
Mda-5: Novel Apoptosis Inducing Gene
$150,116Paul B Fisher · Columbia University Health Sciences · R01 · FY2007 · GM